Literature DB >> 25281477

EMT in cervical cancer: its role in tumour progression and response to therapy.

Rehana Qureshi1, Himanshu Arora2, M A Rizvi3.   

Abstract

The prognosis of cervical patients significantly decreases as the cancer metastasizes to other parts of the body. The epithelial to mesenchymal transition (EMT) plays an important role in cervical cancer progression and metastasis. Recurrence is the primary cause of the increased number of deaths due to cervical cancer. Oncogenes, such as AEG1, Sam-68, FTS and miR-361-5p, induce EMT in cervical cancer. Tumour suppressors, such as LMX-1, SFRP1, klotho, and miR-155, suppress EMT in cervical cancer. Factors such as hypoxia, the radiation dose, cytokines, proteins, transcription factors, and signalling pathways also play an important role in the induction, progression and maintenance of EMT in cervical cancer. Overall, this review describes a wide range of factors with potential roles in EMT that have been identified to date, and this information could be important for the development of new and more effective therapeutics that ameliorate the negative impact of cervical pathogenesis via EMT.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Epithelial Mesenchymal Transition; Mesenchymal transition (EMT); Oncogene; Therapeutics; Tumour-suppressor

Mesh:

Substances:

Year:  2014        PMID: 25281477     DOI: 10.1016/j.canlet.2014.09.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  88 in total

1.  MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7.

Authors:  Boya Deng; Yi Zhang; Siyang Zhang; Fang Wen; Yuan Miao; Kejun Guo
Journal:  Tumour Biol       Date:  2015-05-15

2.  Tissue-Specific Gene Expression during Productive Human Papillomavirus 16 Infection of Cervical, Foreskin, and Tonsil Epithelium.

Authors:  Sreejata Chatterjee; Sa Do Kang; Samina Alam; Anna C Salzberg; Janice Milici; Sjoerd H van der Burg; Willard Freeman; Craig Meyers
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

3.  Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.

Authors:  Boya Deng; Siyang Zhang; Yuan Miao; Yi Zhang; Fang Wen; Kejun Guo
Journal:  Med Oncol       Date:  2015-03-05       Impact factor: 3.064

4.  ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.

Authors:  Weidong Zhao; Huiyan Wang; Xiaohui Han; Jie Ma; Yuanyuan Zhou; Zhengzheng Chen; Hu Zhou; Hanjie Xu; Zhengwei Sun; Beihua Kong; Huiying Fang
Journal:  Tumour Biol       Date:  2016-02-10

5.  Gefitinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial-mesenchymal transition.

Authors:  Jianyun Zheng; Jianxin Yu; Min Yang; Li Tang
Journal:  Exp Ther Med       Date:  2019-07-09       Impact factor: 2.447

6.  Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer.

Authors:  Wei Huang; Shuli Zhu; Qiang Liu; Chanyu Li; Li Li
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

7.  Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.

Authors:  Kanchan Vishnoi; Sutapa Mahata; Abhishek Tyagi; Arvind Pandey; Gaurav Verma; Mohit Jadli; Tejveer Singh; Sukh Mahendra Singh; Alok C Bharti
Journal:  Tumour Biol       Date:  2016-07-24

8.  Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells.

Authors:  Fangfang Guo; Xueqi Fu; Jili Yang; Xueying Zhang; Dezhi Liu; Wenjuan Feng; Jinyu Liu; Jinhong Qi; Huifang Cao; Li Qi; Jingyuan Ren
Journal:  Int J Clin Exp Pathol       Date:  2017-09-01

9.  URI promotes the migration and invasion of human cervical cancer cells potentially via upregulation of vimentin expression.

Authors:  Zhonghai Xu; Huiqin Bian; Fei Zhang; Rui Mi; Qian Wang; Yaojuan Lu; Qiping Zheng; Junxia Gu
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

10.  Elevation of microRNA-512-5p inhibits MUC1 to reduce radioresistance in cervical cancer.

Authors:  Jingru Zhang; Ling Wang; Jing Jiang; Zhiwei Qiao
Journal:  Cell Cycle       Date:  2020-03-03       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.